Abstract Click to copy section linkSection link copied! Monoclonal antibodies, thanks to their high affinity and specificity for their antigen targets, are increasingly used as highly selective therapeutics. While antigen expression and clustering at the cell surface critically influence therapeutic activity, quantifying these effects remains challenging due to the lack of well-defined in vitro platforms that enable precise control over antigen spatial organization and density.
